Insider Buys 9 Meters Biopharma Shares

9 Meters Biopharma Inc NMTR was trading 8.4% higher from the previous closing price. A Form 4 filing filed with the SEC on Monday, September 14 showed that Sirgo Mark A bought 50,000 shares at $0.60 on Thursday, Sep 10, and bought 21,485 shares at $0.65 on Friday, Sep 11.The transaction moved the executive's stake in 9 Meters Biopharma Inc. to 461,784 shares.

The Importance of Insider Transactions

While transactions from an insider shouldn't be used as the sole item to make an investment or trading decision, an insider buying or selling stock in their company can be a good added factor that leads to more conviction in a decision.

When an insider buys stock after an important sell off, that can indicate the insider's faith in the success of the organization. Henceforth, if the stock is bought at new highs, it might be because the insider feels that the stock is not overvalued. Insiders who sell stock at new lows could be anticipating some capitulation moment. If the insider sells at new highs, it could point to the intention to "take some profit" and "lock in a gain."

Important Transaction Codes

Wall Street tends to focus on insider transactions which take place in the open market, viewed inside a Form 4 filing via codes P for purchase and S for sale. If the transaction was an open-market transaction, that means that the insider made a concious decision for the company's stock moving forward.

Transaction codes other than P or S are often viewed with less conviction as they are often not tied to a decision by the exec. As an example, transaction code C indicates the conversion of an option. Transaction code A indicates the insider may have been forced to sell shares in order to receive compensation the exec was promised upon being hired by a company.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsInsider TradesIntraday UpdateMarketsInsider Trade
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...